Comment on: 'Sector retinitis pigmentosa caused by mutations of the RHO gene' (2019)

First Author: Orlans H
Attributed to:  Developing rhodopsin gene therapy to treat dominant retinitis pigmentosa funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41433-019-0648-z

PubMed Identifier: 31659286

Publication URI: http://europepmc.org/abstract/MED/31659286

Type: Journal Article/Review

Parent Publication: Eye

Issue: 8

ISSN: 0950-222X